drugset / Trial / NCT00479505
Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a 12 week study in which different doses of UK-369,003 will be administered to patients with a diagnosis of overactive bladder. Patients will complete a series of questionnaires before treatment, during treatment and after treatment, to assess whether UK-369,003 has improved their symptoms of overactive bladder and erectile function.
Timeline
- Start
- 2007-06
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GISADENAFIL | Small molecule | 10 mg | — |
| Subject | GISADENAFIL | Small molecule | 25 mg | — |
| Subject | GISADENAFIL | Small molecule | 50 mg | — |
| Subject | GISADENAFIL | Small molecule | 100 mg | — |